Molekularpathologische Analyse des K-RAS-Mutationsstatus beim metastasierten kolorektalen Karzinom: Ein Beispiel prädiktiver Pathologie

Author： Dietel M. Tannapfel A. Baretton G. Kreipe H. Kloor M. Gabbert H. Kichner T.

Publisher： Springer Publishing Company

ISSN： 0947-8965

Source： Der Onkologe, Vol.14, Iss.4, 2008-04, pp. : 405-408

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Reduction of invasive potential in K-ras-transformed thyroid cells by restoring of TGF-β pathway

By Nicolussi Arianna D’Inzeo Sonia Gismondi Angela Coppa Anna

Clinical and Experimental Metastasis, Vol. 23, Iss. 5-6, 2006-11 ,pp. : 237-248

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of cytokinesis and akt phosphorylation by chaetoglobosin K in ras-transformed epithelial cells

By Matesic Diane Villio Kimberly Folse Stacey Garcia Erin Cutler Stephen Cutler Horace

Cancer Chemotherapy and Pharmacology, Vol. 57, Iss. 6, 2006-06 ,pp. : 741-754

Springer Publishing Company

Access to resources Recommend Favorite

Chemoimmuntherapie des metastasierten Nierenzellkarzinoms

By Atzpodien J. Reitz M.

Der Onkologe, Vol. 10, Iss. 9, 2004-09 ,pp. : 934-940

Springer Publishing Company

Access to resources Recommend Favorite

Chemotherapie des metastasierten Blasenkarzinoms

By Kollmannsberger C. Albers P. Bokemeyer C.

Der Onkologe, Vol. 8, Iss. 9, 2002-09 ,pp. : 950-961

Springer Publishing Company

Access to resources Recommend Favorite

Genetic susceptibility to thymic lymphomas and K-ras gene mutation in mice after exposure to X-rays and N-ethyl-N-nitrosourea

By Shimada Y. Nishimura M. Kakinuma S. Ogiu T. Fujimoto H. Kubo A. Nagai J. Kobayash K. Tano K. Yoshinaga S. Bhakat K. K.

International Journal of Radiation Biology, Vol. 79, Iss. 6, 2003-06 ,pp. : 423-430

Informa Healthcare

Access to resources Recommend Favorite